|
|
|
Press Releases
All Releases
 |
Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEO
May 15, 2013
|
9.8 KB |
|
| |
HOLLISTON, Mass., May 15, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of Directors has appointed David Green, the Company's President and member of the Board since 1...
|
|
HBIO Reports First Quarter 2013 Results
May 2, 2013
|
36.3 KB |
|
| |
HOLLISTON, Mass., May 2, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial results for the three months ended March 31, 2013.First Quarter Reported Results
Revenue...
|
|
HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. and Announces Its Intended Path Forward
May 1, 2013
|
11.0 KB |
|
| |
HOLLISTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it continues to believe that the best path to maximizing value for its shareholders is to spin-off Harvard...
|
|
Webcast Now Available of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold and "InBreath" Bioreactor
Apr 30, 2013
|
13.5 KB |
|
| |
HOLLISTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- An archived webcast is now available of a press conference held earlier today that detailed the first successful transplant of a regenerated trachea in the United States. The press conference was held at Children's Hospital of Illinois, where the surgery took place, and where the recipient of the...
|
|
Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated Trachea
Apr 30, 2013
|
14.9 KB |
|
| |
HOLLISTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, announces that the "InBreath" tracheal scaffold and bioreactor system manufactured by Harvard Apparatus Regenerative Technolo...
|
|
Harvard Bioscience to Participate in Press Conference Today to Discuss Landmark Surgery
Apr 30, 2013
|
11.3 KB |
|
| |
HOLLISTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, will participate in a press conference today at 11:00 a.m. ET regarding its involvement in a landmark surgery that involved m...
|
|
Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call for May 2, 2013
Apr 26, 2013
|
12.5 KB |
|
| |
HOLLISTON, Mass., April 26, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for its first quarter ended March 31, 2013 before market trading hours on Thursday,...
|
|
HBIO Announces Postponement of the IPO for Harvard Apparatus Regenerative Technology, Inc.
Apr 9, 2013
|
10.2 KB |
|
| |
HOLLISTON, Mass., April 9, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that the planned initial public offering by its wholly-owned regenerative medicine device subsidiary, Harvard...
|
|
HBIO Announces Filing of Request for Acceleration of Effectiveness for Harvard Apparatus Regenerative Technology, Inc.'s IPO Registration Statement
Apr 2, 2013
|
11.5 KB |
|
| |
HOLLISTON, Mass., April 2, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a request for acceler...
|
|
Harvard Bioscience, Inc. Announces Receipt of Private Letter Ruling and Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. Following Its Initial Public Offering
Mar 25, 2013
|
12.6 KB |
|
| |
HOLLISTON, Mass., March 25, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has received a private letter ruling from the Internal Revenue Service that subject to certain condit...
|
|
HBIO Reports Fourth Quarter 2012 Results
Feb 28, 2013
|
48.9 KB |
|
| |
HOLLISTON, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the fourth quarter and full year ended December 31, 2012.Fourth Quarter Rep...
|
|
Harvard Bioscience, Inc. Schedules Fourth Quarter 2012 Conference Call for February 28, 2013
Feb 25, 2013
|
12.8 KB |
|
| |
HOLLISTON, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for its fourth quarter and year ended December 31, 2012 before market trading hours ...
|
|
Harvard Bioscience, Inc. Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology, Inc.
Dec 11, 2012
|
13.7 KB |
|
| |
HOLLISTON, Mass., Dec. 11, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a registration statem...
|
|
HBIO Reports Third Quarter 2012 Results
Nov 1, 2012
|
46.4 KB |
|
| |
HOLLISTON, Mass., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial results for the three and nine months ended September 30, 2012.Third Quarter Reported Resul...
|
|
Harvard Bioscience, Inc. Schedules Third Quarter 2012 Conference Call for November 1, 2012
Oct 26, 2012
|
12.8 KB |
|
| |
HOLLISTON, Mass., Oct. 26, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the third quarter ended September 30, 2012 before market trading hours on Thursd...
|
|
HBIO President David Green to Present at the UBS 2012 Global Life Sciences Conference
Sep 13, 2012
|
11.6 KB |
|
| |
HOLLISTON, Mass., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, today announced that its President, David Green, will present at the UBS 2012 Life Sciences Conference on...
|
|
HBIO Reports Second Quarter 2012 Revenue Growth of 5% Over Second Quarter 2011
Aug 2, 2012
|
46.4 KB |
|
| |
HOLLISTON, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the three and six months ended June 30, 2012.Second Quarter Reported Results...
|
|
Harvard Bioscience, Inc. Schedules Second Quarter 2012 Conference Call for August 2, 2012
Jul 19, 2012
|
12.6 KB |
|
| |
HOLLISTON, Mass., July 19, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the second quarter ended June 30, 2012 before market trading hours on Thursday, ...
|
|
Harvard Bioscience's "InBreath" Bioreactors Used in World's First Successful Regenerated Laryngotracheal Transplants
Jun 26, 2012
|
141.7 KB |
|
| |
HOLLISTON, Mass., June 26, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announces that its "InBreath" bioreactors were used for the world's first and second successful laryngotracheal implants, using s...
|
|
HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011
May 3, 2012
|
38.7 KB |
|
| |
HOLLISTON, Mass., May 3, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial results for the three months ended March 31, 2012.First Quarter Reported Results
Revenue...
|
|
|
=add release to Briefcase Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|
